MBX Capital

CND Life Sciences is a medical diagnostics company focused on developing innovative tools for the diagnosis of neurodegenerative diseases, particularly synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The company has introduced the Syn-One Test, an evidence-based diagnostic tool that detects, visualizes, and quantifies abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. This test provides medical professionals with a convenient, accurate, and minimally invasive method to confirm the presence of synucleinopathy in patients, addressing a critical need for reliable diagnostic options in the field of neurology.

Keebler Health is a technology company that specializes in medical coding assistance. It has developed an AI-driven platform designed to support medical billing teams. This platform, known as a medical coding co-pilot, helps identify and rectify inconsistencies and omissions in coding processes. By doing so, it aims to enhance efficiency among coders, billers, auditors, and physicians, reduce denial rates, and safeguard healthcare providers from coding and billing errors.

Tidal Vision Inc. is a manufacturer based in Ferndale, Washington, specializing in sustainable products derived from ocean waste, particularly salmon skin and crab shells. Founded in 2015, the company produces a range of offerings, including Alaska Salmon leather items such as wallets, belts, shoes, and boots, as well as a variety of chitosan-based products. Chitosan, a biodegradable industrial biopolymer extracted from crab shells, serves multiple applications, including as a fining agent for beverages, a water clarifier, and an antimicrobial agent. Tidal Vision employs a proprietary zero-waste extraction process, ensuring consistent quality and cost-effectiveness in its chitosan products. The company is recognized as a vertically integrated chitosan producer, developing ready-to-use formulations tailored for industries such as water treatment, textiles, and agriculture, thereby promoting environmentally friendly practices.

Waypoint Bio is a biotechnology company focused on developing innovative cell therapy solutions aimed at treating solid tumors in cancer patients. The company leverages a proprietary platform that integrates spatial multi-omics, utilizing advanced artificial intelligence and machine learning techniques. This approach enhances the design of cell therapies and facilitates pooled screening methods, allowing for the creation of effective and safe treatment options. By optimizing cell therapy through the application of spatial biology, Waypoint Bio aims to improve outcomes for patients suffering from challenging cancer types.

Vivodyne is a biotechnology company that specializes in developing an advanced automated robotic system aimed at discovering innovative drugs and cellular therapies. The company has created a microfluidic bioengineering platform that focuses on single-cell 4D phenomics, allowing for a detailed exploration of biological complexities. Its technology enables the cultivation of highly realistic human tissue models for drug discovery, incorporating an integrated confocal microscope. This platform not only accelerates the drug development process but also allows researchers to formulate tunable mixtures of compounds and cell therapies. Through its unique approach, Vivodyne seeks to advance the understanding of human health and facilitate the creation of effective treatments for various diseases.

Forum is a marketplace that specializes in connecting individuals with peer support groups facilitated by trained, mission-driven professionals. Its online platform allows users to engage with others facing similar life challenges, such as career transitions, health issues, and relationship difficulties, all within a digital space that removes geographical barriers. By providing access to a variety of support topics, including grief, loneliness, and caregiving, Forum aims to foster personal change and growth. This approach enables individuals to enhance their mental health and navigate life's obstacles while remaining in the comfort of their own homes, aligning with the company's vision of making peer support widely accessible.

Macro Trials is a developer of a precision research clinical platform aimed at facilitating the connection between pharmaceutical companies and potential trial participants. The company offers an infrastructure designed to simplify the complexities associated with distributed clinical trials, which includes services such as site activation and site monitoring. By collaborating with pharmaceutical companies, physicians, and health systems, Macro Trials helps design, plan, and execute clinical trials for high-value therapeutics. This approach not only enhances research velocity but also allows for a broader range of participants, leading to more generalizable research outcomes. Furthermore, the platform generates valuable longitudinal patient records, contributing to the overall advancement of clinical research and therapeutic development.

Thesis offers personalized brain supplements that cater to all types of brains. They create potent nutritional compounds to improve mental function and provide individualized suggestions depending on their customers' goals and brain chemistry.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing innovative male birth control solutions. The company is pioneering the first long-lasting, non-hormonal, and reversible contraceptive for men. Its primary product, Echo-V, is an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device functions as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and accessible approach to male contraception. Incorporated in 2015, Contraline aims to transform the landscape of reproductive health for men.

Freedom Biosciences is a biotechnology company focused on developing next-generation psychedelic therapeutics. The company aims to create advanced psychedelic pharmaceuticals by harnessing the established pharmacology of compounds such as ketamine. Its mission is to provide innovative treatment options for medical professionals working with patients suffering from resistant depression and various mental disorders. Through its platform, Freedom Biosciences seeks to contribute to the evolving landscape of mental health treatment, addressing the needs of individuals who do not respond to conventional therapies.

Arine Inc. is a San Francisco-based company that specializes in developing a clinical learning and analytic response engine aimed at enhancing medication management and patient care. Founded in 2017, Arine utilizes a data-driven approach to optimize medications and improve health outcomes for patients and their families. The company's platform aggregates and analyzes clinical, social, and behavioral data to identify gaps in patient care, allowing for tailored and actionable medication recommendations. By partnering expert clinicians with data scientists and engineers, Arine focuses on delivering timely interventions that guide patients throughout their healthcare journey, ultimately aiming to lower costs and improve the quality of care.

OFFOR Health is an on-site care delivery organization focused on enhancing access to healthcare services in local communities. By leveraging existing medical and dental facilities, the company aims to reduce surgery backlogs and improve health outcomes for patients, particularly those covered by Medicaid. OFFOR Health specializes in providing pediatric dental anesthesia and is expanding its offerings to include mobile integrated healthcare, community paramedicine, dental-driven primary care, and vaccinations. Utilizing a last-mile logistics network, the organization coordinates specialist anesthesiology care teams, ensuring that patients receive necessary supplies, medications, and equipment directly within their communities, thereby increasing accessibility and reducing overall healthcare costs.

SmileMD is an on-site anesthesia service company bringing anesthesia care teams and logistics to optimize the venue for surgeries. It provides anesthesia to pediatric and adult dental practices in their office setting, reducing anxiety and increasing access to care for thousands of patients each year. They utilize the same safety processes and procedures as hospitals, and our anesthesia care team allows us to provide the highest quality patient care efficiently and safely.

Atlas Labs, Inc. is a technology company that specializes in connecting patients with available medical aid programs to optimize financial assistance. Founded in 2015 and headquartered in San Francisco, California, the company focuses on streamlining patient enrollment in external programs to convert uncompensated care into revenue and reimbursements. Its platform alleviates the burden on financial counselors, reduces patient out-of-pocket expenses, and enhances revenue from third-party programs. Additionally, Atlas Labs organizes and indexes various medical aid programs from government, private, and provider sources, assisting patients in obtaining financial aid while ensuring that medical providers receive reimbursement for self-pay balances. Through its innovative solutions, Atlas Labs aims to improve compliance, enhance margins, and meet community healthcare needs effectively.

Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Freedom Biosciences is a biotechnology company focused on developing next-generation psychedelic therapeutics. The company aims to create advanced psychedelic pharmaceuticals by harnessing the established pharmacology of compounds such as ketamine. Its mission is to provide innovative treatment options for medical professionals working with patients suffering from resistant depression and various mental disorders. Through its platform, Freedom Biosciences seeks to contribute to the evolving landscape of mental health treatment, addressing the needs of individuals who do not respond to conventional therapies.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing innovative male birth control solutions. The company is pioneering the first long-lasting, non-hormonal, and reversible contraceptive for men. Its primary product, Echo-V, is an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device functions as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and accessible approach to male contraception. Incorporated in 2015, Contraline aims to transform the landscape of reproductive health for men.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Attivare Therapeutics is focused on developing innovative biomaterial vaccines and immuno-therapeutics aimed at treating tumors characterized by low immunogenicity. The company's technology creates a unique physical microenvironment within the body that concentrates immune cells, while also delivering immunomodulatory agents to these cells. This approach is designed to effectively reprogram the immune response and overcome tolerance to cancer antigens. By enabling research scientists to develop bioactive components, Attivare Therapeutics seeks to significantly enhance both the magnitude and durability of immune responses in patients, thereby advancing the field of cancer immunotherapy.

CareRev is an innovative healthcare staffing marketplace that connects healthcare facilities directly with per diem medical staff, eliminating intermediaries such as vendors and agencies. This online platform allows hospitals and outpatient facilities to efficiently fill empty shifts, enhancing staffing flexibility while reducing costs. By facilitating direct communication between healthcare providers and clinical professionals, CareRev enables healthcare facilities to maintain adequate nurse-to-patient ratios and improve overall patient care quality. The platform empowers healthcare professionals to choose when and where they work, fostering a more adaptable workforce in the healthcare sector.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that integrate devices, software, and services to support patients in monitoring their health and managing diseases. By bridging the gap between diagnosis and treatment, Vital Bio aims to empower patients and healthcare providers alike, promoting proactive care and reducing disparities in health outcomes. The company's innovative approach seeks to enhance the overall healthcare experience, ensuring that individuals have greater control over their health management.

ixLayer is a leader in the health-tech sector, specializing in precision health testing solutions that facilitate virtual health testing for various stakeholders, including health systems, payors, biopharma, and health-focused organizations. Established in 2018, ixLayer's platform offers comprehensive solutions encompassing technical, security, regulatory, and user experience aspects of complex health testing. As the demand for remote and virtual care continues to grow, ixLayer enhances patient engagement and preventative health strategies by enabling real-time health and wellness lab testing. The platform can be seamlessly integrated with existing patient engagement systems and portals, allowing organizations to efficiently launch and manage testing programs. Serving millions of patients, ixLayer has developed and implemented numerous testing initiatives for large organizations, healthcare systems, and government agencies, contributing to a progressive shift towards telehealth.

AmacaThera Inc. is a clinical-stage biotechnology company based in Toronto, Canada, founded in 2016. The company is focused on developing an innovative injectable hydrogel platform technology designed to enhance drug delivery and improve patient outcomes in various medical applications, particularly in post-surgical pain management, cancer treatment, and other challenging therapeutic areas. AmacaThera's technology features a unique fast-gelling material that liquefies under mechanical force, consisting of a reversible blend of hyaluronan and methylcellulose. This approach allows for localized and sustained drug delivery, potentially reducing postoperative pain and addressing other medical needs effectively.

Concert Health, Inc. is a San Diego-based company that operates an integrated online platform designed to facilitate collaboration between primary care providers and behavioral health specialists. Founded in 2016, the company assists medical groups in incorporating behavioral health services such as screening, therapy, and psychiatric consultations into their practices. Concert Health offers a range of services, including remote clinical staffing with behavioral care managers and psychiatric consultants, as well as tools for registry, workflow management, and reimbursement support. By working directly with primary care teams, Concert Health develops shared care plans that address both physical and mental health conditions, ensuring the delivery of high-quality, evidence-based behavioral health care.

Earli is a biotechnology company focused on advancing cancer detection and treatment through innovative technology. The company specializes in developing devices that utilize a novel gene therapy approach known as Synthetic Biopsy. This method compels cancer cells to produce synthetic biomarkers, which are not naturally occurring in the human body. These biomarkers can then be detected in bodily fluids such as blood, urine, or breath, allowing for early identification of cancer. By facilitating the early detection of homogeneous tumors, Earli aims to significantly improve the chances of successful treatment and personalize therapy options for patients. Additionally, the technology is designed to be visible during imaging procedures such as PET scans, enhancing the monitoring of cancer progression and treatment efficacy.

SecureAire is a company that specializes in active particle control technology aimed at enhancing air filtration efficiency. Its innovative technology targets the removal of critical airborne particles, including bacteria, viruses, allergens, volatile organic compounds, gases, and odors in indoor environments. By effectively reducing or eliminating these harmful particles, SecureAire's solutions help hospitals, commercial buildings, and residential spaces improve air quality, mitigate the risk of sick building syndrome, and curb the transmission of airborne pathogens.

Koneksa Health Inc. is a healthcare data analytics company that specializes in designing and developing software solutions for pharmaceutical and biotech firms. The company’s flagship product, Koneksa Compare, facilitates the collection, monitoring, and analysis of patient-generated data to support clinical studies and regulatory claims. By integrating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires, Koneksa enhances the accuracy and breadth of data that researchers can analyze, thereby minimizing subjective biases in clinical endpoints. Additionally, the platform provides a dashboard that offers electronic clinical outcome assessments and reminders for study participants. Established in 2013 and headquartered in New York, Koneksa also maintains a presence in London, United Kingdom, and is recognized for its contributions to improving the efficiency of drug development through innovative data analysis.

Atlas Labs, Inc. is a technology company that specializes in connecting patients with available medical aid programs to optimize financial assistance. Founded in 2015 and headquartered in San Francisco, California, the company focuses on streamlining patient enrollment in external programs to convert uncompensated care into revenue and reimbursements. Its platform alleviates the burden on financial counselors, reduces patient out-of-pocket expenses, and enhances revenue from third-party programs. Additionally, Atlas Labs organizes and indexes various medical aid programs from government, private, and provider sources, assisting patients in obtaining financial aid while ensuring that medical providers receive reimbursement for self-pay balances. Through its innovative solutions, Atlas Labs aims to improve compliance, enhance margins, and meet community healthcare needs effectively.

Brightside is a financial health company that specializes in providing a comprehensive platform of financial solutions tailored for employers. The company focuses on addressing the needs of the two-thirds of workers living paycheck to paycheck, whose financial struggles can lead to increased turnover, healthcare expenses, and decreased productivity. Brightside's platform offers personalized services that utilize behavioral science to guide employees and their families toward better financial health. By automating positive financial behaviors and providing easy access to curated financial product options, Brightside aims to enhance workforce productivity, retention, and diversity while simultaneously lowering healthcare costs for employers. The integration of tech-powered financial assistants and a user-friendly app further supports employees in making informed financial decisions.

Wellth is a digital health company based in New York that operates a mobile application aimed at improving treatment adherence among individuals with chronic conditions. The platform leverages principles from behavioral economics to address the unique challenges faced by these patients in establishing healthy habits and managing their diseases. By offering targeted incentive plans, reminders, and valuable information, Wellth encourages consumers to take proactive steps toward their health, thus reducing overall healthcare costs. The application's design fosters motivation and behavior change, as it is supported by evidence from randomized controlled trials demonstrating its effectiveness. Wellth's approach has been validated by health plans and providers, resulting in improved medication adherence, reduced hospital readmissions, and better health outcomes for users.

Lucy Goods, Inc. is a company based in Los Angeles, California, that specializes in manufacturing and selling nicotine alternatives to conventional tobacco products. Founded in 2016, Lucy Goods offers a range of products, including nicotine gum available in flavors such as fruit, mint, and cinnamon, as well as nicotine lozenges. The company focuses on providing next-generation nicotine products that utilize pure nicotine and food-grade ingredients, aiming to create a cleaner and more convenient alternative to existing market offerings. Lucy Goods is driven by a mission to eliminate tobacco-related harm entirely. The company's products are primarily sold through online channels.

CloudCath is a company that specializes in developing a sensor-enabled digital platform tailored for patients undergoing peritoneal dialysis. The platform integrates Internet of Things-based sensing hardware with a continuous monitoring system, allowing for the early detection of complications associated with catheter-based treatments. This innovative approach not only enhances patient care by enabling healthcare providers to monitor patients remotely during their home treatments but also aims to reduce the frequency of in-person visits required each month. By focusing on early complication detection, CloudCath seeks to improve patient outcomes in the management of dialysis therapy.

Luna operates a health and wellness center specializing in physical therapies aimed at addressing various conditions such as orthopedic and sports injuries, senior care, post-surgical rehabilitation, and pain management. The company seeks to enhance the effectiveness of physical therapy by providing greater access to care for patients while offering therapists the autonomy and flexibility necessary to manage their careers effectively. Recognizing the challenges faced by both therapists and patients, Luna is committed to creating an environment that fosters independence and motivation, ultimately leading to improved outcomes and greater satisfaction in the therapy process.

Uniform Teeth is an orthodontics practice focused on delivering accessible and high-quality orthodontic care. The company operates dental clinics that utilize a modern approach to treatment, specializing in clear teeth aligners. These aligners are crafted from biocompatible, BPA-free plastic designed to fit snugly over the teeth at each stage of the orthodontic process. By prioritizing patient experience and innovative technology, Uniform Teeth aims to simplify the journey to achieving straightened teeth.

Meissa Vaccines, Inc. is a pharmaceutical development company based in San Mateo, California, established in 2014. The company is dedicated to advancing vaccines for respiratory syncytial virus (RSV), rhinovirus, and human metapneumovirus, targeting significant unmet medical needs, particularly in pediatrics. Meissa Vaccines aims to address the burden of acute lower respiratory tract diseases and the common cold, which are major contributors to healthcare challenges worldwide. Their vaccine programs are designed not only to benefit children but also to have a positive impact across various age groups. By successfully developing vaccines for these viruses, the company seeks to reduce acute asthma exacerbations, alleviate missed school and workdays, and ultimately improve public health outcomes.

Buoy Health, Inc. is a health technology company based in Boston, Massachusetts, with an additional office in New York City. Founded in 2014, Buoy Health develops an artificial intelligence-driven digital health solution designed to empower individuals in managing their health and navigating the healthcare system. The company's primary offering, Buoy Health, is an online healthcare chatbot that provides personalized symptom analysis, facilitates first-line triage, and offers treatment recommendations. This platform functions as a comprehensive resource, enabling users to engage in self-diagnosis and access information about health benefits. Additionally, Buoy Health can be customized for employers to help employees find in-network providers and access wellness programs, thereby enhancing the overall healthcare experience.

Osmosis is a personalized learning platform focused on enhancing health education by providing a deeper understanding of medical concepts. The platform enables clinicians and caregivers to access a wealth of educational resources, including a comprehensive library of videos and multiple-choice questions. Driven by data and technology, Osmosis aims to improve retention and preparedness for courses and exams, making it a valuable tool for medical professionals seeking to deepen their knowledge and skills in the healthcare field. By offering tailored content that goes beyond traditional lectures, Osmosis supports effective learning for a global audience in the medical community.

Mightier is a Boston-based gaming platform established in 2016 that focuses on helping children develop emotional regulation skills through bioresponsive video games. The company's innovative program, developed in collaboration with Boston Children's Hospital and Harvard Medical School, utilizes a heart rate monitor to create a unique gaming experience where the game's difficulty adjusts based on the player's emotional state. This approach allows children to visualize their emotions in real-time, enabling them to learn how to manage their feelings effectively. By engaging with these games, kids with behavioral and emotional challenges can discover their emotional strengths and improve their ability to cope with daily situations.

SafeRide Health is a healthcare technology platform that aims to enhance medical transportation and improve care coordination for patients, particularly those in vulnerable populations. The company's innovative platform combines technology and artificial intelligence to provide health plans with robust tools for managing their members effectively. By delivering end-to-end data transparency, SafeRide Health enhances patient experiences, promotes better population health outcomes, and streamlines healthcare programs. Additionally, the company offers patented fleet management solutions tailored for the healthcare industry, facilitating access to essential care and supporting a more efficient healthcare system while aiming to reduce overall care costs.

SPARK Neuro Inc. is a neuroscience company focused on quantifying brain data to enhance audience engagement in the advertising and entertainment sectors, as well as improving clinical care and therapeutic discovery in healthcare. Founded in 2013 and headquartered in New York, the company utilizes advanced neuroscience tools, including patented neural metrics and machine learning algorithms, to analyze brain activity. Its flagship product, SPARK Scan, is a 10-minute EEG-based evaluation that detects early signs of changes in brain function. By partnering with prestigious institutions, SPARK Neuro aims to deepen the understanding of neurological and psychiatric conditions while making brain health measurement and care more accessible for healthcare professionals.

Opentrons is a company that specializes in the development of pipetting robot technology aimed at automating laboratory experiments. By utilizing open-source principles, Opentrons provides a range of lab automation solutions, including robots, workstations, hardware modules, consumables, reagents, and labware. Their technology leverages the Python programming language to streamline experimental processes, making them faster and reducing the likelihood of human error. This focus on automation allows scientific researchers to enhance efficiency and accuracy in their work, ultimately advancing their research capabilities.

Sonavex, Inc. is a medical technology company based in Baltimore, Maryland, founded in 2013. The company specializes in developing innovative imaging solutions, primarily focusing on ultrasound-based methods to detect anastomotic blood clots and assess vascular health. Sonavex's proprietary technology platform provides clinicians with real-time visualization of critical data at the point of care, enabling them to measure intravascular flow metrics and detect post-operative clots effectively. Additionally, the company has developed bioresorbable and echogenic equipment designed to mark at-risk blood vessels, allowing for future assessments of complications. This technology collects essential data, such as volumetric flow rate and vessel morphology, to enhance patient care in surgical settings, ultimately aiming to improve outcomes for surgical patients.

SwiftShift Ltd. is a London-based company founded in 2012 that focuses on transforming pediatric home care delivery. It creates a nurse-managed service designed to meet the increasing demand for home care, which offers a more effective and cost-efficient alternative to hospital stays for children. SwiftShift connects nurses and clinicians with patients requiring in-home care, allowing caregivers to choose shifts that align with their preferences while ensuring that healthcare providers can effectively market available positions. The company utilizes an AI-based workforce management platform to streamline care coordination, eliminating cumbersome paperwork and enhancing decision-making for nurses. By empowering self-managed care teams, SwiftShift fosters meaningful relationships between patients, families, and caregivers. It is dedicated to improving the nursing experience through continuous professional development and support, ultimately aiming to increase the number of pediatric nurses in the field and ensure every child has access to reliable home care.

EpiBone, Inc. is a biotechnology company based in Brooklyn, New York, that specializes in developing advanced bone and cartilage reconstruction solutions. Founded in 2013, EpiBone leverages innovative techniques involving patient-specific bone scans and the use of the patient's own stem cells to create autologous-like bone grafts. These grafts are cultivated in custom bioreactors, promoting efficient bone formation and regeneration. EpiBone's lead product, an anatomically precise living 3D bone graft, successfully completed its Phase I/IIa clinical trial in August 2023, while the company is also developing a cartilage repair portfolio that includes an allogeneic osteochondral plug and an injectable cartilage filler. This pioneering work positions EpiBone at the forefront of regenerative medicine, aiming to transform orthopedic repair and improve patient outcomes through a streamlined surgical approach and reduced recovery times.

Perceptive Navigation LLC is a pre-clinical stage medical device company based in Baltimore, Maryland, focused on developing innovative interventional medical devices for the image-guided surgery market. The company is known for its flagship product, Vu-Path, an intracorporeal ultrasound device that integrates front-viewing ultrasound imaging with a working portal. This unique combination allows for the precise introduction of needles, biopsy instruments, guide wires, and therapeutic agents into the body. Vu-Path aims to enhance the safety and efficacy of minimally invasive procedures across multiple medical disciplines, including radiology, cardiology, interventional oncology, and urology. Traditional imaging techniques often pose challenges such as high costs, complexity, and risks associated with patient safety. Vu-Path addresses these issues by facilitating quicker and safer access to internal organs while reducing the need for extensive training and equipment. With its patented technology, Perceptive Navigation seeks to transform the landscape of interventional medicine, improving outcomes for both patients and healthcare providers.

MHB Labs is a biotechnology company focused on developing innovative products for men's health. Founded in 1999 and based in Chestnut Hill, Massachusetts, MHB Labs specializes in creating pharmaceutical solutions aimed at addressing conditions such as erectile dysfunction, Peyronie’s disease, and delayed orgasm. The company is also engaged in the development of AndroSphere, a product specifically designed for men’s health. Additionally, MHB Labs advises on projects involving medical devices and telemedicine, collaborating with startups to enhance patient care through advanced technology. By leveraging clinical insights and forming strategic partnerships, MHB Labs aims to address unmet medical needs and bring impactful health solutions to market.

Persist AI is a company that aids pharmaceutical firms in the development of long-acting drug formulations by leveraging artificial intelligence and automation. Traditional formulation development is a lengthy process, typically spanning 5 to 10 years, which includes extensive pre-clinical and clinical testing phases. Persist AI aims to significantly reduce this timeline by streamlining pre-clinical formulation development to just three months, enhancing the efficiency of the drug development process by 50%. The company employs AI-driven automation technologies, such as automated drug release testing and high-throughput formulation screening, to facilitate quicker and more reliable drug formulation. By doing so, Persist AI not only accelerates drug development but also contributes to improving patient outcomes.

Catena Biosciences is a biotechnology firm focused on advancing protein conjugation technology to address autoimmune disorders and other medical challenges. The company specializes in a method that facilitates the rapid and selective attachment of proteins, utilizing natural amino acids such as tyrosine and cysteine. This innovative approach allows researchers to develop novel therapeutics across various fields, including autoimmune disorders, oncology, and vaccine development. By streamlining the process of building biologic structures, Catena Biosciences aims to enhance medical research and contribute to the creation of effective treatments.

Vivodyne is a biotechnology company that specializes in developing an advanced automated robotic system aimed at discovering innovative drugs and cellular therapies. The company has created a microfluidic bioengineering platform that focuses on single-cell 4D phenomics, allowing for a detailed exploration of biological complexities. Its technology enables the cultivation of highly realistic human tissue models for drug discovery, incorporating an integrated confocal microscope. This platform not only accelerates the drug development process but also allows researchers to formulate tunable mixtures of compounds and cell therapies. Through its unique approach, Vivodyne seeks to advance the understanding of human health and facilitate the creation of effective treatments for various diseases.